| Autor: |
Xiaoxiong, Gan, Fei, Shen, Xingyan, Deng, Jianhua, Feng, Jiabao, Lu, Wensong, Cai, Lina, Peng, Weipeng, Zheng, Weijia, Wang, Peidan, Huang, Zhen, Chen, Mengli, Guo, Bo, Xu |
| Rok vydání: |
2019 |
| Předmět: |
|
| Zdroj: |
Oncology Letters |
| ISSN: |
1792-1074 |
| Popis: |
The BRAF-V600E mutation is the most common and specific oncogenic event known in papillary thyroid carcinoma (PTC). However, it remains controversial whether there is an association between the BRAF-V600E mutation and clinicopathologically aggressive characteristics of PTC. The purpose of the present retrospective study was to investigate the significance of the BRAF-V600E mutation in predicting prognostic and aggressive clinicopathological characteristics according to a new age-based stratification. Clinical data and the BRAF-V600E mutation status of 475 patients with PTC were downloaded from The Cancer Genome Atlas database. The association between BRAF-V600E status and clinicopathological characteristics was analyzed by χ2 test or Fisher's exact test. Recurrence-free survival rate (RFS) was analyzed using the Kaplan-Meier method. Aggressive clinicopathological factors associated with recurrence were analyzed by Cox multivariate regression. This study was conducted on 219 cases of patients with PTC with a known BRAF-V600E mutational status. In the ≥55 years age group, BRAF-V600E was found to be significantly associated with aggressive PTC characteristics, including tumor size, PTC subtype, radioactive iodine (RAI) dose, follow-up time, recurrence, recurrence risk stage, advanced T stage, advanced N stage and American Joint Committee on Cancer (III/IV) stage (all P |
| Databáze: |
OpenAIRE |
| Externí odkaz: |
|
